| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0003 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |